Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 938

1.

Polysaccharides from fermented Momordica charantia ameliorate obesity in high-fat induced obese rats.

Wen JJ, Gao H, Hu JL, Nie QX, Chen HH, Xiong T, Nie SP, Xie MY.

Food Funct. 2019 Jan 10. doi: 10.1039/c8fo01609g. [Epub ahead of print]

PMID:
30628614
2.

Nephrotoxicity and highly active antiretroviral therapy: Mitigating action of Momordica charantia.

Offor U, Naidu EC, Ogedengbe OO, Jegede AI, Peter AI, Azu OO.

Toxicol Rep. 2018 Sep 20;5:1153-1160. doi: 10.1016/j.toxrep.2018.09.003. eCollection 2018.

3.
4.

A new seed-transmissible begomovirus in bitter gourd (Momordica charantia L.).

Manivannan K, Renukadevi P, Malathi VG, Karthikeyan G, Balakrishnan N.

Microb Pathog. 2018 Dec 21;128:82-89. doi: 10.1016/j.micpath.2018.12.036. [Epub ahead of print]

PMID:
30583019
5.

Comparison of antidiabetic effects of saponins and polysaccharides from Momordica charantia L. in STZ-induced type 2 diabetic mice.

Wang Q, Wu X, Shi F, Liu Y.

Biomed Pharmacother. 2019 Jan;109:744-750. doi: 10.1016/j.biopha.2018.09.098. Epub 2018 Nov 5.

6.

Study of pancreatic lipase inhibition kinetics and LC-QTOF-MS-based identification of bioactive constituents of Momordica charantia fruits.

Chanda J, Mukherjee PK, Biswas R, Malakar D, Pillai M.

Biomed Chromatogr. 2018 Dec 9:e4463. doi: 10.1002/bmc.4463. [Epub ahead of print]

PMID:
30536964
7.

Effect of Bitter Melon Extracts on Lipid Levels in Japanese Subjects: A Randomized Controlled Study.

Kinoshita H, Ogata Y.

Evid Based Complement Alternat Med. 2018 Nov 8;2018:4915784. doi: 10.1155/2018/4915784. eCollection 2018.

8.

Chemosynthesis and characterization of site-specific N-terminally PEGylated Alpha-momorcharin as apotential agent.

Sun W, Sun J, Zhang H, Meng Y, Li L, Li G, Zhang X, Meng Y.

Sci Rep. 2018 Dec 7;8(1):17729. doi: 10.1038/s41598-018-35969-1.

9.

Administration of Momordica charantia Enhances the Neuroprotection and Reduces the Side Effects of LiCl in the Treatment of Alzheimer's Disease.

Huang HJ, Chen SL, Chang YT, Chyuan JH, Hsieh-Li HM.

Nutrients. 2018 Dec 3;10(12). pii: E1888. doi: 10.3390/nu10121888.

10.

Oxalate content of raw, wok-fried, and juice made from bitter gourd fruits.

Bong WC, Savage G.

Food Sci Nutr. 2018 Oct 23;6(8):2015-2019. doi: 10.1002/fsn3.706. eCollection 2018 Nov.

11.

Safety and efficacy of Momordica charantia Linnaeus in pre-diabetes and type 2 diabetes mellitus patients: a systematic review and meta-analysis protocol.

Peter EL, Deyno S, Mtewa A, Kasali FM, Nagendrappa PB, Sesaazi D, Tolo CU, Ogwang PE.

Syst Rev. 2018 Nov 15;7(1):192. doi: 10.1186/s13643-018-0847-x.

12.

Mapping and QTL Analysis of Gynoecy and Earliness in Bitter Gourd (Momordica charantia L.) Using Genotyping-by-Sequencing (GBS) Technology.

Gangadhara Rao P, Behera TK, Gaikwad AB, Munshi AD, Jat GS, Boopalakrishnan G.

Front Plant Sci. 2018 Oct 31;9:1555. doi: 10.3389/fpls.2018.01555. eCollection 2018.

13.

Enzymes inhibitors from natural sources with antidiabetic activity: A review.

Alam F, Shafique Z, Amjad ST, Bin Asad MHH.

Phytother Res. 2019 Jan;33(1):41-54. doi: 10.1002/ptr.6211. Epub 2018 Nov 11. Review.

PMID:
30417583
14.

Bitter melon (Momordica charantia) attenuates atherosclerosis in apo-E knock-out mice possibly through reducing triglyceride and anti-inflammation.

Zeng Y, Guan M, Li C, Xu L, Zheng Z, Li J, Xue Y.

Lipids Health Dis. 2018 Nov 6;17(1):251. doi: 10.1186/s12944-018-0896-0.

15.

Preparation of a Momordica charantia L. polysaccharide‑chromium (III) complex and its anti-hyperglycemic activity in mice with streptozotocin-induced diabetes.

Zhang C, Huang M, Hong R, Chen H.

Int J Biol Macromol. 2019 Feb 1;122:619-627. doi: 10.1016/j.ijbiomac.2018.10.200. Epub 2018 Nov 2.

PMID:
30391593
16.

Antihyperglycemic and Antilipidemic Effects of the Ethanol Extract Mixture of Ligularia fischeri and Momordica charantia in Type II Diabetes-Mimicking Mice.

Baek HJ, Jeong YJ, Kwon JE, Ra JS, Lee SR, Kang SC.

Evid Based Complement Alternat Med. 2018 Oct 2;2018:3468040. doi: 10.1155/2018/3468040. eCollection 2018.

17.

Momordica charantia L. lowers elevated glycaemia in type 2 diabetes mellitus patients: Systematic review and meta-analysis.

Peter EL, Kasali FM, Deyno S, Mtewa A, Nagendrappa PB, Tolo CU, Ogwang PE, Sesaazi D.

J Ethnopharmacol. 2019 Mar 1;231:311-324. doi: 10.1016/j.jep.2018.10.033. Epub 2018 Oct 30. Review.

PMID:
30385422
18.

Molecular concept of diabetic wound healing: effective role of herbal remedies.

Soliman A, Teoh SL, Ghafar N, Das S.

Mini Rev Med Chem. 2018 Oct 25. doi: 10.2174/1389557518666181025155204. [Epub ahead of print]

PMID:
30360709
19.

Cucurbitane triterpenoids from the fruit of Momordica charantia L. and their anti-hepatic fibrosis and anti-hepatoma activities.

Yue J, Sun Y, Xu J, Cao J, Chen G, Zhang H, Zhang X, Zhao Y.

Phytochemistry. 2019 Jan;157:21-27. doi: 10.1016/j.phytochem.2018.10.009. Epub 2018 Oct 22.

PMID:
30352327
20.

Momordica charantia extracts protect against inhibition of endothelial angiogenesis by advanced glycation endproducts in vitro.

Aljohi A, Matou-Nasri S, Liu D, Al-Khafaji N, Slevin M, Ahmed N.

Food Funct. 2018 Nov 14;9(11):5728-5739. doi: 10.1039/c8fo00297e.

PMID:
30318521

Supplemental Content

Loading ...
Support Center